Sorrento Therapeutics, Inc. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from Q1 2017 to Q1 2023

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
Sorrento Therapeutics, Inc. quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from Q1 2017 to Q1 2023.
  • Sorrento Therapeutics, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending March 31, 2023 was 0.21 pure, unchanged year-over-year.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 0.21 0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 0.21 0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q1 2021 0.21 0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-05
Q1 2020 0.21 Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
Q1 2018 0.21 -0.14 -40% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-10
Q1 2017 0.35 Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.